Kits (1)
オンライン (1)
Human (1)
- (1)
- (1)
| 製品番号 | 種 | 発現システム | 製品説明 | タンパク質の構造 | 純度 | 特性 |
|---|---|---|---|---|---|---|
EP-149 | - | IL-13RA2 [Biotinylated] : IL-13 Inhibitor Screening ELISA Kit |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Girentuximab-Zr-89 | TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TX250 | Phase 3 Clinical | Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Cholangiocarcinoma; Sarcoma; Nasopharyngeal Carcinoma; Contrast agents; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms | 詳細 | |
| Lutetium-177 DOTA girentuximab | TLX-250 | Phase 2 Clinical | Heidelberg, Telix Pharmaceuticals Ltd | Solid tumours; Carcinoma, Renal Cell; Neoplasms | 詳細 |
| [177Lu]Lu-DPI-4452 | [177Lu]Lu-DPI-4452 | Phase 2 Clinical | Debiopharm International Sa | Carcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal | 詳細 |
| Debio-0328 | [68Ga]Ga-DPI-4452; Gallium-68-DPI-4452 | Phase 2 Clinical | Debiopharm International Sa | Carcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal | 詳細 |
| PMI-05 | PMI-05 | Phase 1 Clinical | Precision Molecular Inc | Neoplasms | 詳細 |
| Girentuximab | MAb-G250; cG250; WX-G250 | Phase 1 Clinical | Kidney Neoplasms; Carcinoma, Renal Cell | 詳細 | |
| PHC-102 | PHC102; 99mTc-CAIX | Phase 1 Clinical | Philochem | Carcinoma, Renal Cell | 詳細 |
| Indium-111-DOTA-girentuximab-IRDye800CW (Radboud University) | Phase 1 Clinical | Radboud University Nijmegen | Carcinoma, Renal Cell; Diagnostic agents | 詳細 | |
| CA9hu-1 | CA9hu-1 | Phase 1 Clinical | Mabpro AS | Head and Neck Neoplasms; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Mesothelioma; Carcinoma, Non-Small-Cell Lung | 詳細 |
| Sulfamide-nitroimidazole | Clinical | Dualtpharma | Neoplasms | 詳細 | |
| PD-32766 | PD-32766; 64Cu-PD-32766; 225Ac-PD-32766 | Clinical | PeptiDream Inc | Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Glioblastoma; Triple Negative Breast Neoplasms; Colorectal Neoplasms | 詳細 |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



